¿Qué es DUROLANE?

DUROLANE es una terapia exclusiva de una sola inyección de ácido hialurónico que proporciona un alivio del dolor duradero para la osteoartritis.2

¿Qué es DUROLANE?

DUROLANE es una terapia exclusiva de una sola inyección de ácido hialurónico (AH) de alto peso molecular que proporciona alivio duradero del dolor de la OA de rodilla y actúa como lubricante y amortiguador complementario. El AH de DUROLANE se hace con el mismo material que el AH natural del interior del cuerpo humano.1,5,33

¿Qué hace que DUROLANE sea único?

A diferencia de otros AH, DUROLANE está hecho con la tecnología exclusiva patentada NASHA®, que le da una estructura de perlas de gel. Esto hace que DUROLANE sea más resistente a la degradación con el paso del tiempo y proporcione alivio duradero del dolor con una sola inyección.9,38

 

¿Cómo puede ayudar DUROLANE?

stretching
Alivio del dolor
icon-proven-safety
Seguridad
other-provided-services
Comodidad
physical-activity
Mejora de la calidad de vida
DUROLANE-middle-whatis

Escoger DUROLANE significa menos tiempo buscando aliviar el dolor y más tiempo haciendo lo que le gusta.

Summary of Indications for Use

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.